Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.066
Sell
RSI(14)
31.634
Neutral
STOCH(KDJ)(9,3,3)
1.913
Oversold
ATR(14)
0.288
Low Volatility
CCI(14)
-120.171
Sell
Williams %R
98.772
Oversold
TRIX(12,20)
-1.765
Sell
StochRSI(14)
0.000
Sell
Aethlon Medical Inc
AEMD2.490USD
-0.170-6.39%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
189.57KMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Aethlon Medical Inc
Currency: USD Updated: 2025-12-24Key Insights
Aethlon Medical Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 132/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 12.38.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Aethlon Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Hold
Current Rating
12.375
Target Price
+214.09%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Aethlon Medical Inc Highlights
StrengthsRisks
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Overvalued
The company’s latest PE is -0.02, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.62.
Financial Health
Currency: USD Updated: 2025-12-24The current financial score of Aethlon Medical Inc is 6.83, ranking 124/206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.67
Operational Efficiency
2.77
Growth Potential
6.78
Shareholder Returns
6.92
Aethlon Medical Inc's Company Valuation
Currency: USD Updated: 2025-12-24The current valuation score of Aethlon Medical Inc is 7.19, ranking 117/206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.02, which is -70.73% below the recent high of -0.00 and -693.29% above the recent low of -0.13.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 132/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-24The current earnings forecast score of Aethlon Medical Inc is 6.00, ranking 174/206 in the Healthcare Equipment & Supplies industry. The average price target for Aethlon Medical Inc is 12.38, with a high of 15.00 and a low of 9.75.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
12.375
Target Price
+214.09%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
90
Total
4
Median
7
Average
Company name
Ratings
Analysts
Aethlon Medical Inc
AEMD
2
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-24The current price momentum score of Aethlon Medical Inc is 6.42, ranking 146/206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.14 and the support level at 1.66, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.744
Sell
MA10
2.936
Sell
MA20
3.487
Sell
MA50
4.263
Sell
MA100
7.244
Sell
MA200
15.687
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-24The current institutional shareholding score of Aethlon Medical Inc is 3.00, ranking 135/206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 5.57%, representing a quarter-over-quarter decrease of 90.04%. The largest institutional shareholder is James Simons, holding a total of 4.60K shares, representing 0.34% of shares outstanding, with 1.00% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2025-12-24The current risk assessment score of Aethlon Medical Inc is 1.04, ranking 199/206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.59. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.59
VaR
+9.40%
240-Day Maximum Drawdown
+91.80%
240-Day Volatility
+468.62%
Return
Best Daily Return
60 days
+14.87%
120 days
+97.30%
5 years
+388.22%
Worst Daily Return
60 days
-23.49%
120 days
-45.62%
5 years
-53.10%
Sharpe Ratio
60 days
-3.31
120 days
-0.79
5 years
-0.06
Risk Assessment
Maximum Drawdown
240 days
+91.80%
3 years
+95.74%
5 years
+99.76%
Return-to-Drawdown Ratio
240 days
+2.98
3 years
-0.18
5 years
-0.18
Skewness
240 days
+3.41
3 years
+2.91
5 years
+19.08
Volatility
Realised Volatility
240 days
+468.62%
5 years
+255.45%
Standardised True Range
240 days
+37.40%
5 years
+43.83%
Downside Risk-Adjusted Return
120 days
-137.36%
240 days
-137.36%
Maximum Daily Upside Volatility
60 days
+94.21%
Maximum Daily Downside Volatility
60 days
+89.03%
Liquidity
Average Turnover Rate
60 days
+20.66%
120 days
+10.88%
5 years
--
Turnover Deviation
20 days
+61.60%
60 days
-39.11%
120 days
-67.95%
Peer Comparison
Healthcare Equipment & Supplies
Aethlon Medical Inc
AEMD
5.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Aethlon Medical Inc?
The TradingKey Stock Score provides a comprehensive assessment of Aethlon Medical Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Aethlon Medical Inc’s performance and outlook.
How do we generate the financial health score of Aethlon Medical Inc?
To generate the financial health score of Aethlon Medical Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Aethlon Medical Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Aethlon Medical Inc.
How do we generate the company valuation score of Aethlon Medical Inc?
To generate the company valuation score of Aethlon Medical Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Aethlon Medical Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Aethlon Medical Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Aethlon Medical Inc.
How do we generate the earnings forecast score of Aethlon Medical Inc?
To calculate the earnings forecast score of Aethlon Medical Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Aethlon Medical Inc’s future.
How do we generate the price momentum score of Aethlon Medical Inc?
When generating the price momentum score for Aethlon Medical Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Aethlon Medical Inc’s prices. A higher score indicates a more stable short-term price trend for Aethlon Medical Inc.
How do we generate the institutional confidence score of Aethlon Medical Inc?
To generate the institutional confidence score of Aethlon Medical Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Aethlon Medical Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Aethlon Medical Inc.
How do we generate the risk management score of Aethlon Medical Inc?
To assess the risk management score of Aethlon Medical Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Aethlon Medical Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Aethlon Medical Inc.
